ImmunoCellular Therapeutics (IMUC) Stock Price Up -3%

ImmunoCellular Therapeutics Ltd (NYSEAMERICAN:IMUC) shares rose 3% during trading on Tuesday . The stock traded as high as $0.35 and last traded at $0.32. Approximately 1,305,100 shares were traded during mid-day trading, a decline of 14% from the average daily volume of 1,522,216 shares. The stock had previously closed at $0.33.

The stock has a market cap of $7.52, a PE ratio of -0.11 and a beta of 1.04.

COPYRIGHT VIOLATION WARNING: “ImmunoCellular Therapeutics (IMUC) Stock Price Up -3%” was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The original version of this piece of content can be accessed at https://www.chaffeybreeze.com/2018/01/04/immunocellular-therapeutics-imuc-stock-price-up-3.html.

ImmunoCellular Therapeutics Company Profile

ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is developing immune-based therapies for the treatment of cancers. The Company’s cancer immunotherapies target cancer stem cells (CSCs), which are the drivers of tumor growth and disease recurrence. Its product candidate is ICT-107, which is in phase III testing.

Receive News & Ratings for ImmunoCellular Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoCellular Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply